Evidence map›Paper›PMID 29322939›Full record

ArticleEpidemiology and psychiatric sciences2018

Public health psychopharmacology: a new research discipline comes of age?

C Barbui, G Ostuzzi, B Godman

Abstract read
In one paragraph

Article in Epidemiology and psychiatric sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

C BarbuiDepartment of Neuroscience,WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation,Biomedicine and Movement Sciences,Section of Psychiatry,University of Verona,Verona,Italy.
G OstuzziDepartment of Neuroscience,WHO Collaborating Centre for Research and Training in Mental Health and Service Evaluation,Biomedicine and Movement Sciences,Section of Psychiatry,University of Verona,Verona,Italy.
B GodmanStrathclyde Institute of Pharmacy and Biomedical Sciences,Strathclyde University,Glasgow,UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Research evidence guiding the identification of pragmatic and effective actions aimed at improving the selection, availability, affordability and rational prescribing of medicines for mental disorders is sparse and inconsistent. In order to boost the development of new research, in this commentary we suggest to organise and classify all the activities in this area under a common theoretical framework and nomenclature, adopting the term 'public health psychopharmacology'. Public health psychopharmacology is proposed as a research discipline, based on contributions from the fields of regulatory science, health services research and implementation science. Implementing the term public health psychopharmacology may offer advantages, as the scientific community would be more focused on common goals and objectives, with, likely, an increasing body of research evidence of practical use.

Indexed as

PsychopharmacologyPublic HealthDrugs, EssentialHealth Services AccessibilityHumansMental DisordersMental Health ServicesPsychotropic DrugsDrugs, EssentialPsychotropic DrugsAffordabilityavailabilitypsychotropic medicinesrational prescribingselection of medicines

Identifiers

PMID29322939
PMCPMC6998875

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.